8 pre-IPO tech giants – what you need to know

Space, AI, defense, and brain-computer interfaces decoded

In today's capital markets, a group of "tech giants" remains private but not for long. From SpaceX, OpenAI, and Anthropic, which are driving the space and AI revolutions, to Kalshi and Polymarket, which are reshaping how people trade on real-world events — these companies are rewriting the future of Nasdaq.

What exactly are they building? When will they go public? Today, we break down 8 major pre-IPO companies and their growth potential.

1. SpaceX: The ultimate interstellar platform

  • Core business: Commercial space launches (Starship), global satellite internet (Starlink)

  • Valuation: $1.5 trillion

  • IPO timeline: Confidential S-1 filed with the SEC on April 1, 2026; earliest listing expected June 2026 – potentially the largest IPO ever

  • Growth potential: SpaceX is far more than a rocket company. Starlink is generating massive cash flow (projected $7.2B EBITDA in 2025). In February 2026, SpaceX also acquired xAI, combining space infrastructure with top-tier AI computing, creating unmatched long-term upside.

Buy SpaceX with USDT/USDC

2. OpenAI: The leading force toward AGI

  • Core business: Foundation AI models (GPT, Sora, Codex), parent of ChatGPT

  • Valuation: $852B

  • IPO timeline: Expected late 2026 (likely Q4)

  • Growth potential: After raising $122B in March 2026, OpenAI reached ~$25B annual revenue. Enterprise clients now account for over 40%, and GPT-5.4 is reshaping global workflows. Its dual advantage in compute and distribution positions it as the "next Apple" of the AI era.

Buy OpenAI with USDT/USDC

3. Anthropic: The enterprise AI leader

  • Core business: Claude AI models focused on safety and code generation

  • Valuation: $380B (secondary market >$800B)

  • IPO timeline: Earliest October 2026

  • Growth potential: A top OpenAI competitor, Anthropic raised $30B in 2026. Its Claude Code product now powers ~4% of GitHub commits, driving revenue past $30B. Backing from Amazon and Google strengthens its infrastructure advantage.

Buy Anthropic with USDT/USDC

4. xAI: Musk's fast-scaling AI bet

  • Core business: AI development (Grok model)

  • Valuation: $230B

  • IPO timeline: Already merged into SpaceX (Feb 2026)

  • Growth potential: After integrating with X (Twitter), xAI gained massive real-time data access. With $3.8B annual revenue and a massive GPU cluster ("Colossus 2"), it is positioned strongly in the agentic AI space.

  • Note: xAI tokens can be converted into SpaceX tokens.

Buy xAI with USDT/USDC

5. Kalshi: The leader in regulated prediction markets

  • Core business: CFTC-regulated event trading platform

  • Valuation: $22B

  • IPO timeline: Not announced

  • Growth potential: Prediction markets are emerging as a trillion-dollar sector. Kalshi raised $1B+ in 2026, doubling its valuation in three months. Monthly trading volume exceeded $10B, taking share from both betting and traditional hedging markets.

Buy Kalshi with USDT/USDC

6. Polymarket: The global Web3 prediction leader

  • Core business: Decentralized prediction markets

  • Valuation: $15B

  • IPO timeline: Likely to remain token-based or private

  • Growth potential: Acts as a real-time barometer for global events. Backed by ICE (NYSE parent), with total market volume reaching $25.7B in March 2026. Increasingly used by institutions for macro hedging.

Buy Polymarket with USDT/USDC

7. Anduril: The new defense tech powerhouse

  • Core business: Autonomous drones, AI defense systems (Lattice OS)

  • Valuation: ~$60B

  • IPO timeline: Likely 2026–2027

  • Growth potential: Competing directly with traditional defense giants, Anduril generated $2B revenue in 2025 and secured a $22B US Army contract. Its automated weapons factory launching in 2026 gives it strong margin advantages.

Buy Anduril with USDT/USDC

8. Neuralink: The brain-computer interface pioneer

  • Core business: Implantable brain-computer interfaces

  • Valuation: $9.65B

  • IPO timeline: Likely post-2028

  • Growth potential: Neuralink leads the high-end BCI space. Clinical trials have already restored speech and vision functions in some patients. Musk aims to scale production by 2026, turning BCI into a mainstream human enhancement technology.

Buy Neuralink with USDT/USDC

Disclaimer: Tokens referenced in this article are onchain mapped assets and do not represent actual equity or ownership in the underlying companies. Market caps are based on onchain data and may not reflect real-world valuations. Always do your own research before trading. Please refer to the Prestocks risk disclosure for full details.

Trade what's trending early